US Army funds Kumetrix silicon shock sensor
This article was originally published in Clinica
The US Army is funding the development of a miniature sensor that would continuously monitor the blood of battlefield casualties for signs of internal bleeding and shock. The Army has awarded a $120,000 grant to Union City, California-based Kumetrix for a feasibility study of the sensor.
You may also be interested in...
Novartis’s cancer drug has now been filed for multiple sclerosis in the US, armed with a priority review, and in Europe.
Aetion is also working with the US Food and Drug Administration and a number of biopharma companies on projects involving use of real-world evidence.
Increased fines and penalties are on the cards for manufacturing facilities that fail to comply with proposed new requirements.